Product Information
NAPROXEN 125 MG/5 ML SUSPEN is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1216 per ML under NDC 69238173002. Its NADAC has been published 185 times since Mar 22, 2023.
FDA first approved this application on Jul 31, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/mL
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238173002
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NAPROXENApproval Type
Generic (ANDA)
FDA Application
ANDA212705FDA Approved
7/31/2020
TE Code
AB
On Market Since
8/3/2020
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN 125 MG/5 ML SUSPEN has been published 185 times since Mar 22, 2023, and over the history we have for it it has declined 79.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1216 per ML |
|---|---|
| All-time high | $0.5917 (Apr 10, 2024) |
| All-time low | $0.1075 (Jul 22, 2026) |
| 52-week high | $0.2858 |
| 52-week low | $0.1075 |
| Median price | $0.2858 |
| Average price | $0.3421 |
| Largest weekly change | -61.9% (Apr 17, 2024) |
| Weeks tracked | 185 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naproxen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAPROXEN 125 MG/5 ML SUSPEN?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 125 MG/5 ML SUSPEN, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1216 per ML (NDC 69238173002), effective Sep 30, 2026.
How has the price of NAPROXEN 125 MG/5 ML SUSPEN changed over time?
Over the history we have for it, the NADAC for NAPROXEN 125 MG/5 ML SUSPEN has declined 79.5%. It has been tracked across 185 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for NAPROXEN 125 MG/5 ML SUSPEN?
Since Mar 22, 2023, the NADAC for NAPROXEN 125 MG/5 ML SUSPEN has ranged from a low of $0.1075 (Jul 22, 2026) to a high of $0.5917 (Apr 10, 2024), with a median of $0.2858 per ML.
Are there cheaper alternatives to NAPROXEN 125 MG/5 ML SUSPEN?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NAPROXEN 125 MG/5 ML SUSPEN in a comparable dosage form, but none are currently priced below it.
Who manufactures NAPROXEN 125 MG/5 ML SUSPEN?
NAPROXEN 125 MG/5 ML SUSPEN (NDC 69238173002) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.